Archer Aviation vs. Karman: Which Aerospace Stock Is a Better Buy in 2026?

The article compares Archer Aviation and Karman on growth, profitability, valuation, and risk, ultimately favoring Karman as the better 2026 buy. Archer reported FY2025 revenue of just $300,000 and a $618.2 million net loss, though it ended Q1 with $1.8 billion in cash and a $1.5 billion conditional United order book. Karman posted FY2025 revenue of $471.5 million, 36.6% growth, and $17.4 million in net income, with Q1 revenue up 51% year over year to a record $151.2 million.

Analysis

KRMN is the cleaner near-term winner because the market is still underwriting execution risk like a pre-revenue story, while the business is already compounding inside a defense backlog ecosystem that tends to be stickier than headline multiples imply. The second-order benefit is that a profitable, cash-generative supplier with recurring mission-critical content can keep winning mix even if prime contractors slow procurement, because it sits lower in the value chain and is harder to displace than a new platform vendor.

ACHR remains a financing and certification trade rather than a traditional operating equity. The hidden risk is that every delay in certification or commercialization extends the period where cash burn is the dominant driver of valuation, and that can quickly overwhelm optionality even with a large cash balance. JOBY is the most obvious read-through loser if investors start distinguishing between “credible path to revenue” and “story premium,” since any skepticism around eVTOL timelines compresses the whole sub-sector.

The consensus may be underestimating how much KRMN’s customer concentration is offset by program criticality. In defense, concentration is less toxic when the product is embedded in mission assurance; the real hazard is not one lost customer but a broad procurement pause or contract repricing cycle, which is a slower-moving risk than the market typically prices. For ACHR, the upside is real but the market likely needs one of two catalysts: first commercial ops without major setbacks, or a strategically meaningful defense/AI contract that proves the company can diversify away from pure eVTOL optionality.

Positioning-wise, this favors owning KRMN on dips and treating ACHR as a small-call-option allocation only. The spread should continue to favor the profitable incumbent unless ACHR shows revenue inflection that changes the financing overhang. If ACHR slips on certification headlines or capital-raise rumors, that is the better entry for shorts or relative-value expressions.

Key Decisions for Investors

• Long KRMN on weakness over the next 1-3 months; target a move back toward prior highs as the market rewards profitable growth and de-risks the recent equity overhang. Risk/reward is favorable because downside should be limited by existing fundamentals, while upside is driven by multiple re-rating if execution stays clean.
• Use ACHR only as a small long-dated call-style exposure, not a core equity position. Prefer 6-12 month horizon with defined downside; the thesis requires certification/commercial milestones, so avoid size until revenue visibility improves.
• Pair trade: long KRMN / short ACHR for a 3-6 month relative-value setup. This isolates the market’s preference for cash flow and reduces beta to aerospace sentiment while capturing the valuation gap between execution and optionality.
• If you want eVTOL exposure, prefer JOBY only on capitulation, not momentum. The read-through from ACHR is that the group will likely trade on regulatory proof points, so any position should be sized for binary headline risk.
• Watch for any ACHR capital raise or schedule slip as a tactical short signal over days to weeks. Those events would likely reset the market from ‘future platform’ to ‘ongoing dilution story,’ which is where drawdowns can accelerate.